Skip to main content

Arrhythmia Monitoring Devices Market Trends 2020: Comprehensive Insights on Top Key Players, Technological Scope

  "Arrhythmia Monitoring Devices Market Research Report - Forecast to 2025” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2025.

 Arrhythmia Monitoring Devices Market Report Information by Device Type (Resting ECG, Event Monitor, Holter Monitor, Others), by Application (Tachycardia, Bradycardia, Others), By End User (Hospitals and Clinics, Others) and Region­­ - Global Forecast till 2024

Market Highlights

The Global Arrhythmia Monitoring Devices Market is Expected to Register a CAGR of 6.44% and is Anticipated to Reach USD 8,087.4 Million by 2024. Cardiac arrhythmia monitoring devices are extremely useful in tracking the functions of the heart function and report any abnormalities in the normal function (rhythm). Hence, they do not just help in maintaining a continuous record of heart functions but have also proven to be lifesavers due to their ability to report abnormalities in normal heart functions, like in the case of a cardiac event.

Intended Audience

  • Medical Device Manufacturers and Distributors
  • Government Research Organizations
  • Hospitals and Clinics
  • Regulatory Agencies

Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/6714

The global market for arrhythmia monitoring devices is expected to propel owing to factors such as increasing use of telecardiology, ease of use and portability of cardiac arrhythmia monitoring devices, and development of smart cardiac monitors. However, the factors such as an increase in recalls of arrhythmia monitoring devices and complications related to these devices may hamper the growth of the market over the forecast period.

Segment Analysis

The global arrhythmia monitoring devices market has been segmented into device type, application, and end user. By device type, the market has been segmented into resting ECG, event monitor, implantable cardiac monitor (ICM), Holter monitor, mobile cardiac telemetry (MCT) devices, others. On the basis of application, the market has been segmented into tachycardia, bradycardia, atrial fibrillation (A-fib), ventricular fibrillation (V-fib), premature ventricular contractions (PVC), conduction disorders, and others. By end user, the market has been segmented into hospitals & clinics, diagnostic centers, home care settings, ambulatory surgery centers (ASC), and others.

Key Players

Market Research Future (MRFR) recognizes the following companies as the key players in the global arrhythmia monitoring devices market that includes are Biotronik (Germany), Abbott Laboratories (US), Medtronic plc (Ireland), GE Healthcare (US), BioTelemetry, Inc. (US), Applied Cardiac Systems, Inc. (US), Alive Cor, Inc. (US), Nihon Kohden Corporation (Japan), Fukuda Denshi Co. Ltd (Japan), and Spacelabs Healthcare (US).

Regional Analysis

Geographically, the Americas is expected to dominate the global arrhythmia monitoring devices market. In this region, the growing prevalence of cardiac diseases along with growing awareness created by several government organizations as well as private firms is estimated to support the market growth. The Europe arrhythmia monitoring devices market is expected to be the second largest market owing to the growing occurrences of cardiac disorders in the region. In the European region, Spain accounted for a market share of 5.5% in 2018. Asia-Pacific is anticipated to be the fastest growing market owing to the developing healthcare infrastructure and rising disposable income. Furthermore, the Middle East and Africa is expected to witness steady growth due to limited access and healthcare affordability among the population.

Key Findings of the Study

  • Global arrhythmia monitoring devices market is projected to reach USD 8,087.4 million by 2024 with 44% CAGR during the review period of 2019 to 2024.
  • Americas accounted for the largest share in the region due to the high adoption rate of the low-cost electrocardiogram and the rising prevalence of cardiac diseases.
  • The hospital and clinics segment accounted for the largest share, holding a market value of USD 1,740.0 Million in 2018.

Access Report Details @  https://www.marketresearchfuture.com/reports/arrhythmia-monitoring-devices-market-6714

The report for Global market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.

TOC:

  1.  Report Prologue    

    2.    Market Introduction   


          2.1    Definition    

          2.2    Scope of the Study    

                2.2.1    Research Objective    

                2.2.2    Assumptions    

                2.2.3    Limitations    

    3.    Research Methodology

          3.1    Introduction

          3.2    Primary Research    

          3.3    Secondary research

          3.4    Market Size Estimation

    TOC…Continued

Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/6714

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Comments

Popular posts from this blog

Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Growth Drivers, Restraints and Opportunities, Forecast To 2025

Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size Research Report: Information by Treatment (Drug Class (Mitogen-Activated Protein Kinases (MAPK) Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors, Others), Oxygen Therapy, Lung Transplant, Others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025 Global  Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size  Insights 2020 provides a unique tool for evaluating the Market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability. Some of the key players operating for the global market analysis are  Boehringer Ingelheim GMBH, Biogen, Novartis AG, Medicinova, Inc., Bristol-Myers Squibb Company, Galapagos NV, F. Hoffmann-La R...

Peptic Ulcer Drugs Market Rapid Development By Manufactures Business Growth Future

  Peptic Ulcer Drugs Market Scenario: Peptic ulcer drugs are used to treat erosion of the gastrointestinal lining due to a variety of factors. Peptic ulcer is the result of an imbalance between aggressive and defensive fluids in the stomach. Peptic ulcer includes gastric, esophageal and duodenal ulcer. The global peptic ulcer drugs market was valued at approximately $29 billion in 2015, and is expected to reach $36.27 billion by 2022. Thus, the market is expected to show an average growth at a CAGR of 3.8 % from 2016 to 2022. The major driving factors for petic ulcers drug market are stress, drug induced ulcers, growing rate of infection by H.Pyrroli, changes in food, rise in cancer, tobacco and alcohol use. Constraining factors of this market are patent expiry, comparatively good treatment regimen of proton pump inhibitors, resistance of H.Pyrolli, extreme market fragmentation into many companies and great penetration of generics. Avail a Free Sample@  https://www.market...

North America wheelchair transportation Market by Leading Key Players, Product Applications in that Regional Forecast 2028

  North America Active Wheelchair Market Overview: The North America Active Wheelchair Market size is expected to grow at more than 7.7% CAGR to reach above USD 970 million by 2028 from a little above USD 502 million in 2019. Explore 27 market data Tables spread through nearly 57 Pages and in-depth analysis on “North AmericaActive Wheelchair market By Type (Manual, Powered), Indication (Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Diabetes, Cerebral Palsy, Muscular Dystrophy, Parkinson’s Disease, Scoliosis, Spina Bifida, Spinal Cord Injury) and by Country (US, Canada, Mexico), Regional Trends and Forecast from 2019 to 2028. Global North America active  wheelchair transportation   Market research provides a detailed Analytical Insights of global Market size, regional and country-level scope, segmentation wise growth, global share, Competition Scenario, sales analysis, impact global Market players on domestic players, value chain optimization, tra...